Company Filing History:
Years Active: 2009-2015
Title: John Ziemniak: Innovator in Pharmaceutical Formulations
Introduction
John Ziemniak is a notable inventor based in Gwynedd Valley, PA (US). He holds 4 patents that focus on innovative pharmaceutical preparations aimed at improving patient care and treatment efficacy. His work has significantly contributed to the field of drug delivery systems, particularly for conditions affecting the breast and urogenital tract.
Latest Patents
Ziemniak's latest patents include formulations for topical or local administration of drugs directly to the breast or chest. These formulations are designed to produce a regional or local effect while minimizing systemic drug levels. In a preferred embodiment, the drug is applied to the surface of the breast, areola, or directly to the nipple. This method enhances patient comfort and increases bioavailability, resulting in higher drug concentrations in the targeted area with fewer side effects compared to systemic administration. The formulations often utilize micro or nanoparticles, which can be combined with excipients or carriers to modify release rates and enhance absorption. Additionally, he has developed drug delivery compositions suitable for vaginal administration, which can take various forms such as tablets, liquid suspensions, or topical ointments. This innovative approach reduces the systemic levels of the drugs, providing a more effective treatment option.
Career Highlights
Throughout his career, Ziemniak has worked with Femmepharma Holding Company, Inc. and Femmepharma Holding Company, Inc. His contributions to these organizations have been instrumental in advancing pharmaceutical technologies and improving patient outcomes.
Collaborations
Ziemniak has collaborated with notable professionals in the field, including Gerianne Tringali DiPiano and Peter Kevin Mays. These partnerships have fostered innovation and development in pharmaceutical formulations.
Conclusion
John Ziemniak's work in pharmaceutical innovations demonstrates his commitment to enhancing drug delivery systems and improving patient care. His patents reflect a deep understanding of the complexities involved in treatment methodologies, making him a significant figure in the field of pharmaceuticals.